Add Yahoo as a preferred source to see more of our stories on Google. AUGUSTA, Ga. (WJBF) – A clinic at the Georgia Cancer Center that focuses on a rare condition is getting a special designation in ...

Please provide your email address to receive an email when new articles are posted on . Survey responses reflected positive language and communication outcomes after cannabidiol use. Further ...

Patients with tuberous sclerosis complex, a genetic disorder characterized by the growth of noncancerous tumors in multiple organs of the body, have limited treatment options. A team led by ...

RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced ...

The Company plans to discontinue further clinical development of ganaxolone in TSC. Marinus Pharmaceuticals announced that its phase 3 trial of ganaxolone did not meet the primary end point for the ...

In early childhood, a woman developed multiple red papules on the nose and cheeks with the appearance of angiofibromas (see Figure 1). As an adult, papules formed around her toes which were consistent ...

Tuberous sclerosis complex (TSC) is a rare genetic disease (approximate 1:6,000 birth incidence) with a wide variability of physical and neuropsychiatric symptoms. Patients require lifelong care from ...

Please provide your email address to receive an email when new articles are posted on . The FDA recently announced its approval of the cannabis-based Epidiolex, an oral solution to treat seizures in ...

A team of researchers led by UCL Great Ormond Street Institute of Child Health (ICH) and Great Ormond Street Hospital (GOSH) has found that metformin - a drug commonly used to treat Type 2 diabetes - ...

Tuberous sclerosis complex and von Hippel–Lindau disease are distinct autosomal dominant tumor suppressor syndromes that can exhibit similar renal phenotypes and seem to share some signaling pathway ...

The cannabidiol (CBD) oral solution Epidiolex has been approved by the US Food and Drug Administration (FDA) for the new indication of treatment of seizures associated with tuberous sclerosis complex ...